The main risk is not technical irrelevance; it is value capture and timing. Ambarella has credible products, a cash cushion, and real edge-AI demand, but one dominant distributor, outsourced
advanced-node supply, and long customer qualification cycles can all delay or dilute the payoff. If
CV7 ramps slip or mix stays concentrated, the stock can remain a niche semiconductor story rather than a compounding edge-AI platform.